BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3480085)

  • 21. Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol.
    Band PR; Silverberg DS; Henderson JF; Ulan RA; Wensel RH; Banerjee TK; Little AS
    N Engl J Med; 1970 Aug; 283(7):354-7. PubMed ID: 5468406
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of lactate infusion on renal transport of purine bases and oxypurinol.
    Yamamoto T; Moriwaki Y; Takahashi S; Nasako Y; Higashino K
    Nephron; 1993; 65(1):73-6. PubMed ID: 8413795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xanthine calculi in the patient with the Lesch-Nyhan syndrome associated with urinary tract infection.
    Oka T; Utsunomiya M; Ichikawa Y; Koide T; Takaha M; Mimaki T; Sonoda T
    Urol Int; 1985; 40(3):138-40. PubMed ID: 3925607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe hyperphosphatemia following acute tumor lysis syndrome.
    Vachvanichsanong P; Maipang M; Dissaneewate P; Wongchanchailert M; Laosombat V
    Med Pediatr Oncol; 1995 Jan; 24(1):63-6. PubMed ID: 7968798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Allopurinol-induced kidney failure with hepatitis and squamous dermatitis in pre-existing kidney insufficiency].
    Pewsner D; Bachmann C; Müller U
    Schweiz Med Wochenschr; 1987 Jan; 117(4):139-41. PubMed ID: 2950589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postchemotherapy purine excretion in lymphoma patients receiving allopurinol.
    Hande KR; Hixson CV; Chabner BA
    Cancer Res; 1981 Jun; 41(6):2273-9. PubMed ID: 7237428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Xanthine nephropathy during chemotherapy in deficiency of hypoxanthine-guanine phosphoribosyltransferase.
    Gomez GA; Stutzman L; Chu TM
    Arch Intern Med; 1978 Jun; 138(6):1017-9. PubMed ID: 348139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allopurinol and xanthine nephropathy.
    Wyngaarden JB
    N Engl J Med; 1970 Aug; 283(7):371-2. PubMed ID: 5468407
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparative study on the hypouricemic activity and potency in renal xanthine calculus formation of two xanthine oxidase/xanthine dehydrogenase inhibitors: TEI-6720 and allopurinol in rats.
    Horiuchi H; Ota M; Kobayashi M; Kaneko H; Kasahara Y; Nishimura S; Kondo S; Komoriya K
    Res Commun Mol Pathol Pharmacol; 1999; 104(3):307-19. PubMed ID: 10741381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allopurinol or oxypurinol in heart failure therapy - a promising new development or end of story?
    Reyes AJ; Leary WP
    Cardiovasc Drugs Ther; 2005 Oct; 19(5):311-3. PubMed ID: 16382292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allopurinol in patients with impaired renal function.
    Levin NW; Abrahams OL
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):681-7. PubMed ID: 5958698
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of glucagon on renal excretion of oxypurinol and purine bases.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hiroishi K; Yamakita J; Nakano T; Higashino K
    J Rheumatol; 1997 Apr; 24(4):708-13. PubMed ID: 9101506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allopurinol in renal failure and the tumour lysis syndrome.
    Simmonds HA; Cameron JS; Morris GS; Davies PM
    Clin Chim Acta; 1986 Oct; 160(2):189-95. PubMed ID: 3780009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous determination of allopurinol, oxipurinol, hypoxanthine and xanthine in biological fluids by high-performance liquid chromatography.
    Boulieu R; Bory C; Baltassat P; Gonnet C
    J Chromatogr; 1984 May; 307(2):469-74. PubMed ID: 6736196
    [No Abstract]   [Full Text] [Related]  

  • 35. Allopurinol metabolism in a patient with xanthine oxidase deficiency.
    Yamanaka H; Nishioka K; Suzuki T; Kohno K
    Ann Rheum Dis; 1983 Dec; 42(6):684-6. PubMed ID: 6689118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obstructive uropathy and severe acute kidney injury from renal calculi due to adenine phosphoribosyltransferase deficiency.
    Chong SL; Ng YH
    World J Pediatr; 2016 May; 12(2):243-5. PubMed ID: 26684317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral uric acid, xanthine, and hypoxanthine after ischemia: the effect of allopurinol.
    Nihei H; Kanemitsu H; Tamura A; Oka H; Sano K
    Neurosurgery; 1989 Oct; 25(4):613-7. PubMed ID: 2797398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperuricemia complicating leukemia: treatment with allopurinol and dialysis.
    Maher JF; Rath CE; Schreiner GE
    Arch Intern Med; 1969 Feb; 123(2):198-200. PubMed ID: 5249562
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute renal failure caused by extreme hyperphosphatemia after chemotherapy of an acute lymphoblastic leukemia.
    Boles JM; Dutel JL; Briere J; Mialon P; Robasckiewicz M; Garre M; Briere J
    Cancer; 1984 Jun; 53(11):2425-9. PubMed ID: 6585264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous assay of hypoxanthine, xanthine and allopurinol by high-performance liquid chromatography and activation of immobilized xanthine oxidase as an enzyme reactor.
    Kito M; Tawa R; Takeshima S; Hirose S
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2459-62. PubMed ID: 2605692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.